Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02730845
Other study ID # R/ 15.10.40
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2015
Est. completion date May 30, 2016

Study information

Verified date September 2020
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study will be carried to evaluate the efficacy of intra-articular 0.5 bupivacaine with intra-articular or intravenous alpha-2agonist; Dexmedetomidine; for intraoperative anesthesia and postoperative analgesia after arthroscopic knee surgery.

Arthroscopic knee surgery is one of the most common minimally invasive orthopedic procedures in recent practice which is frequently performed as a day surgery procedures. It can be done under general, regional or local anesthesia (LA) with or without sedation. It is associated with varying amount of postoperative pain. Postoperative pain negatively influences patient's early ambulation, rehabilitation and psychology which consecutively prolonged the hospital stay.

Intra-articular administration of local anesthetic for knee arthroscopy is a well-documented procedure that offers many advantages over other anesthesia types. Many anesthesiologists are still trying to improve the technique of local anesthetic administration through using many combinations with LA solutions in order to administer safe anesthesia to those patients and to obtain a pain-free knee with good operating conditions.

Dexmedetomidine is a highly selective α2 adrenergic agonist. It has analgesic, sedative, anxiolytic, hypnotic, sympatholytic, antihypertensive properties with anesthetic sparing effects. It becomes an attractive alternative to the current opioids because it does not have a respiratory depressant or addictive effect.


Description:

All patients were kept fasting after midnight and received midazolam 5 mg orally as premedication. All patients were premedicated with I.V. midazolam 0.03 mg/kg ten minutes before starting the operation. The anesthetic technique was standardized for all patients. All surgical procedures were performed by the same surgeon and consisted of arthroscopic removal of torn meniscus. Both intra-articular and intravenous solutions were prepared by an individual not involved in the study and the intra-articular drugs were injected by the surgeon (without knowing the contents). The anesthesiologist managing and monitoring the patient throughout the surgery provides IV drugs. No leg holder or tourniquet or surgical drain was used for any of the cases. After preparation and draping the patient's leg, patients were warned prior to each needle stick to decrease anxiety. All procedures were performed under complete aseptic conditions. Skin and subcutaneous tissues at each arthroscopic portal site were anesthetized with LA consisting of injection of a mixture of 2% lidocaine 5 mL with 1:200,000 epinephrine.

Care should be taken to avoid infiltration of the fat pad. It is a relatively aneural structure; as, too much local infiltration allows it to bulge out into the joint during the surgery. Flexion and extension of the knee joint several times help to spread of intra-articular solution and then waiting 20 minutes for anesthesia to take effect is helpful before the surgical incision.

The arthroscope was inserted into the knee, and inflow through the sheath was established. No pump was used for the saline inflow which was maintained through the arthroscope by the gravity. Gravity outflow drained through the superolateral portal. A separate egress cannula was used if indicated. The patient was encouraged to view the video monitor during the procedure. Constant verbal communication between the surgeon and the patient is important throughout the arthroscopic examination and surgery. This keeps the patient anxiety and muscle tension to the minimum which facilitates manipulation of the leg and thorough examination of the entire joint. Once finishing, instruments were removed and portals were closed with a 4-0 absorbable suture subcutaneously and steri-strips. A compression dressing was applied for three days to the knee.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date May 30, 2016
Est. primary completion date April 1, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists physical status I or II

- Patients scheduled for elective unilateral knee arthroscopy

Exclusion Criteria:

- Refusal of local anesthesia

- History of cardiovascular disease

- History of cerebrovascular disease

- History of respiratory diseases

- History of impaired renal functions

- History of impaired hepatic functions

- Pregnancy

- Allergy to the study drugs

- Uncontrolled diabetes

- Coagulopathies

- Hypertension treated with a methyldopa, clonidine or ß adrenergic blockers

- Patients receiving chronic pain treatment

- Patients receiving psychoactive drugs

- Patients receiving anticoagulant drugs

- Prior ipsilateral knee surgery

- Infection at site of injection

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Intra-articular dexmedetomidine
Patients will receive an intra-articular mixture of 19 ml bupivacaine 0.5% with epinephrine 1:200.000 added to 1ml (1 µg/kg) of dexmedetomidine (total volume 20 ml), and i.v. saline 20 ml infused over 10 min starting with local anesthesia
Intravenous dexmedetomidine
Patients will be injected intra-articularly with mixture of 19 ml 0.5% bupivacaine with epinephrine 1:200.000 and 1 ml of isotonic saline (total volume 20 ml), in addition to i.v. 20 ml saline containing 1 µg/kg dexmedetomidine over 10 min infusion starting with local anesthesia.

Locations

Country Name City State
Egypt Mansoura University Hospitals Mansoura DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain scores Pain will be assessed using 10 cm visual analogue scale (VAS) for 24 hours starting immediately before performing the procedure
Secondary Heart rate starting immediately before performing the procedure
Secondary Blood pressure Changes in systolic and mean blood pressure starting immediately before performing the procedure
Secondary Oxygen saturation Changes in peripheral oxygen saturation starting immediately before performing the procedure
Secondary Respiratory rate Changes in respiratory rates will be recorded starting immediately before performing the procedure
Secondary Level of sedation will be evaluated using the following scale: (5= awake/alert to 0= asleep/unarousable ) For 24 hours after performing the injection
Secondary Patient Satisfaction Score will be assessed using the following scale: 5= very satisfied, 4= satisfied, 3 = neutral, 2 = dissatisfied,
1 = very dissatisfied
For 24 hours after performing the procedure
Secondary Time to first postoperative analgesic requirement This will be recorded as the time to first postoperative analgesic requirement For 24 hours after performing the injection
Secondary Intraoperative and postoperative side effects These include nausea, vomiting, hypotension, bradycardia, respiratory depression, Hypertension For 24 hours after performing the injection
Secondary Time to mobilization out of bed will be recorded in minutes from skin closure For 48 hours after performing the procedure
Secondary Post-anesthesia care unit (PACU) length of stay will be recorded from time between transfer from the operating room to PACU and discharge For 4 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06098391 - Results at More Than 10 Years of Meniscal Sutures Without Avivement
Completed NCT04467359 - Application of Rapid Rehabilitation Nursing in Perioperative Rehabilitation of Knee Arthroscopy N/A
Not yet recruiting NCT05090670 - The Impact of Germanium-Embedded Knee Brace on Patient Recovery After Knee Arthroscopy N/A
Completed NCT05822973 - Sutures for Treatment of Knee Arthroscopy N/A
Not yet recruiting NCT06112223 - Preemptive Oral Gabapentin and Tramadol on Postoperative Pain After Knee Arthroscopy N/A
Completed NCT04130412 - Open Versus Arthroscopic Release for Lateral Patellar Compression Syndrome: Comparative Study N/A
Completed NCT04308772 - Web-Based Physiotherapy Following Knee Arthroscopy N/A
Terminated NCT03365752 - Chloroprocaine Spinal for Outpatient Knee Surgery Phase 2
Not yet recruiting NCT03926000 - Pregabalin Premedication for Knee Arthroscopy N/A
Withdrawn NCT01112878 - Oral Clonidine & Gabapentin: Improving Recovery and Pain Management After Outpatient With Major Orthopedic Surgery Phase 4
Completed NCT00799149 - Etoricoxib Versus Gabapentin for Knee Arthroscopy Phase 4
Terminated NCT03173326 - Patient Satisfaction and Postoperative Analgesia Between Subarachnoid Block With 2-chloroprocaine Versus General Anesthesia for Knee Arthroscopy N/A
Terminated NCT02174770 - Blood Flow Restriction Training in Rehabilitation Patients N/A
Completed NCT01247376 - Temperature Sensitive Release of PGE2 and Diminished Energy Requirements in Synovial Tissue With Postoperative Cryotherapy - A Prospective Randomised Study After Knee Arthroscopy N/A
Withdrawn NCT02294045 - Analysis of Joint Sounds in the Diagnosis of Knee Disorders
Completed NCT04566250 - Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin) N/A
Completed NCT02411890 - Postoperative Pain Between ACB and FNB After ACLR Phase 4
Terminated NCT04561375 - Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery Phase 4
Completed NCT05580640 - Investigating the Efficacy of Osteopathic Manipulative Treatment on Gait Dysfunction Following Knee Surgery N/A
Completed NCT00803725 - Spinal Mepivicaine With Fentanyl for Outpatient Knee Arthroscopy N/A